NO943723L - Anvendelse av kinolin-3-karboksamidforbindelser for behandling av diabetes - Google Patents

Anvendelse av kinolin-3-karboksamidforbindelser for behandling av diabetes

Info

Publication number
NO943723L
NO943723L NO943723A NO943723A NO943723L NO 943723 L NO943723 L NO 943723L NO 943723 A NO943723 A NO 943723A NO 943723 A NO943723 A NO 943723A NO 943723 L NO943723 L NO 943723L
Authority
NO
Norway
Prior art keywords
diabetes
quinoline
hydrogen atoms
treatment
compound
Prior art date
Application number
NO943723A
Other languages
English (en)
Norwegian (no)
Other versions
NO943723D0 (no
Inventor
Shimon Slavin
Lola Weiss
David Gross
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of NO943723D0 publication Critical patent/NO943723D0/no
Publication of NO943723L publication Critical patent/NO943723L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO943723A 1992-04-06 1994-10-05 Anvendelse av kinolin-3-karboksamidforbindelser for behandling av diabetes NO943723L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9201076A SE9201076L (sv) 1992-04-06 1992-04-06 Användningen av gamla läkemedel för behandling av diabetes
PCT/SE1993/000272 WO1993019756A1 (en) 1992-04-06 1993-03-31 The use of quinoline-3-carboxamide compounds for treatment of diabetes

Publications (2)

Publication Number Publication Date
NO943723D0 NO943723D0 (no) 1994-10-05
NO943723L true NO943723L (no) 1994-10-05

Family

ID=20385863

Family Applications (1)

Application Number Title Priority Date Filing Date
NO943723A NO943723L (no) 1992-04-06 1994-10-05 Anvendelse av kinolin-3-karboksamidforbindelser for behandling av diabetes

Country Status (16)

Country Link
US (1) US5594005A (ja)
EP (1) EP0634931A1 (ja)
JP (1) JPH07506568A (ja)
KR (1) KR950700738A (ja)
CN (1) CN1081671A (ja)
AU (1) AU667362B2 (ja)
CA (1) CA2131831C (ja)
EE (1) EE03090B1 (ja)
HU (1) HUT69710A (ja)
IL (1) IL105285A0 (ja)
NO (1) NO943723L (ja)
NZ (1) NZ251494A (ja)
PH (1) PH30820A (ja)
SE (1) SE9201076L (ja)
WO (1) WO1993019756A1 (ja)
ZA (1) ZA932450B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802550D0 (sv) * 1998-07-15 1998-07-15 Active Biotech Ab Quinoline derivatives
SE9802549D0 (sv) * 1998-07-15 1998-07-15 Active Biotech Ab Quinoline derivatives
US6133285A (en) * 1998-07-15 2000-10-17 Active Biotech Ab Quinoline derivatives
FR2827600A1 (fr) * 2001-07-20 2003-01-24 Lipha Derives acides de quinolone et leurs applications en therapeutique
US8124582B2 (en) * 2002-12-06 2012-02-28 Fibrogen, Inc. Treatment of diabetes
EP2351559B1 (en) * 2008-10-09 2015-08-12 Newtree Co., Ltd. Novel use of panduratin derivative or boesenbergia pandurata extract
MX2013004169A (es) * 2010-10-14 2013-06-05 Immunahr Ab 1, 2-dihidro-4-hidroxi-2-oxo-quinolina-3-carboxanilidas como activadores del receptor de hidrocarburo aromatico.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1034124A (en) * 1973-05-11 1978-07-04 Ciba-Geigy Ag Process for the manufacture of new quinolines
FR2340735A1 (fr) * 1976-02-11 1977-09-09 Roussel Uclaf Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament
IE52670B1 (en) * 1981-03-03 1988-01-20 Leo Ab Heterocyclic carboxamides,compositions containing such compounds,and processes for their preparation
DE3134780A1 (de) * 1981-09-02 1983-03-10 Hoechst Ag, 6000 Frankfurt "sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung"
US5310913A (en) * 1989-06-09 1994-05-10 Kabi Pharmacia Aktiebolag Derivatives of quinoline-3-carboxanilide
SE9000624D0 (sv) * 1990-02-22 1990-02-22 Pharmacia Ab New use
SE9001111D0 (sv) * 1990-03-27 1990-03-27 Pharmacia Ab Supportive use

Also Published As

Publication number Publication date
AU667362B2 (en) 1996-03-21
SE9201076L (sv) 1993-10-07
CA2131831A1 (en) 1993-10-14
KR950700738A (ko) 1995-02-20
WO1993019756A1 (en) 1993-10-14
HU9402854D0 (en) 1995-01-30
PH30820A (en) 1997-10-17
AU3913193A (en) 1993-11-08
SE9201076D0 (sv) 1992-04-06
NO943723D0 (no) 1994-10-05
EP0634931A1 (en) 1995-01-25
NZ251494A (en) 1997-07-27
HUT69710A (en) 1995-09-28
EE03090B1 (et) 1998-06-15
US5594005A (en) 1997-01-14
JPH07506568A (ja) 1995-07-20
CA2131831C (en) 1999-03-09
IL105285A0 (en) 1993-08-18
ZA932450B (en) 1993-10-20
CN1081671A (zh) 1994-02-09

Similar Documents

Publication Publication Date Title
AP2000001786A0 (en) Therapeutic uses of quinoline derivatives.
NO173234C (no) Chelatdannere til kompleksdannelse av radioaktive isotoper, deres metallkomplekser, saavel som deres anvendelse i diagnostikk
BR0214164A (pt) Ligantes do receptor canabinóide
CA2036304A1 (en) Pyrimidinedione derivatives, their production and use
NZ333302A (en) Substituted 6,5-hetero-bicyclic derivatives for the prevention or inhibition of a disorder that can be treated by antagonising corticotropin releasing factor
YU1501A (sh) Derivati hinolina
PL335518A1 (en) 1,8-cycled n- or c-bound imidazole substituted derivatives of quinolynone inhibiting farnesil transferase
PL364221A1 (en) Fused heterocyclic compounds
HUP9801219A2 (hu) Triciklusos N-acilezett benzazepin és benzoxazepinszármazékok, az ezeket tartalmazó gyógyszerkészítmények, eljárás előállításukra
CA2112331A1 (en) Novel naphthalene derivatives
MY113733A (en) Salts of an anti-migraine indole derivative
NO941273L (no) Ny anvendelse av substituert kinolinkarboksamid
NO924929L (no) Farmasoeytisk aktive benzoquinazolinforbindelser
NO943723L (no) Anvendelse av kinolin-3-karboksamidforbindelser for behandling av diabetes
SE9302490D0 (sv) New use of old drugs
ES2126890T3 (es) Preparacion de complejos de monociclopentadienilo con metales mediante sustitucion nucleofila de complejos de bis(ciclopentadienilo) con metales.
DK0613687T3 (da) Anvendelse af pregnanderivat til behandling af tumorer
RU95106653A (ru) Производные 2-имидазолин-5-онов и 2-имидазолин-5-тионов и фунгицидные композиции на их основе
SE9400809D0 (sv) New use of quinoline-3-carboxamide compounds
TW344742B (en) Indole derivatives and the medical used thereof
SE9400810D0 (sv) New use of Quinoline-3-carboxamide compounds
EP0543018A4 (en) Antidiabetic
NO914375L (no) 7-acyl-3-(substituerte carbamoyloxy)cefem-forbindelser ogfremgangsmaate for fremstilling av disse
GB1252847A (ja)
GB1337371A (en) 3-amino-imidazo-1,5-a- pyridines processes for their preparation and pharmaceutical compositions incorporating them